Grand Pharmaceutical Group — Simcere Zaiming
Tracked across 1 events · 11 articles · First seen Jul 20, 2026 · Last active Sep 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: The licensor of SIM0660, this subsidiary gains significant financial upside and validation of its T-cell engager platform, potentially accelerating its development and commercialization.
Jul 20, 2026 · 11 articles
ERGEN INTELLIGENCE
Track Grand Pharmaceutical Group — Simcere Zaiming live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard